Leading prodrug strategies for targeted and specific release
- 14 March 2025
- journal article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 17 (8) , 865-868
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancerEuropean Journal of Medicinal Chemistry, 2023
- Stimuli‐Responsive Prodrug Chemistries for Cancer TherapyChemBioChem, 2023
- Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugatesJournal of Controlled Release, 2023
- The role of endolysosomal trafficking in anticancer drug resistanceDrug Resistance Updates, 2021
- Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug MonotherapyNano Letters, 2020
- Photoactivatable Prodrug-Backboned Polymeric Nanoparticles for Efficient Light-Controlled Gene Delivery and Synergistic Treatment of Platinum-Resistant Ovarian CancerNano Letters, 2020
- A bio-responsive 6-mercaptopurine/doxorubicin based “Click Chemistry” polymeric prodrug for cancer therapyMaterials Science and Engineering: C, 2020
- 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomasJournal of Neuro-Oncology, 2019
- Oxygen Activation and Radical Transformations in Heme Proteins and MetalloporphyrinsChemical Reviews, 2017
- Lipid–Drug Conjugate for Enhancing Drug DeliveryMolecular Pharmaceutics, 2017